Global Canine Atopic Dermatitis Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, And Growth Forecast To 2029

                                          
Global Canine Atopic Dermatitis Market  2021: By Product (Glucocorticoids, Antihistamines, Immunosuppressants, MAbs, Others), By Mode of Administration (Topical, Oral, Injectable), By Distribution Channel (Veterinary Hospitals/Clinics, Retail, E-commerce)

Global Canine Atopic Dermatitis Market is the title of an upcoming report offered by Trusted Business Insights. The report contains information and data, and inputs from both primary and secondary data sources, that have been verified and validated by experts in the target market. The report presents a thorough study of revenues, historical data, and information, key developments, and strategies by major players that offer vital insights and perspectives in various scenarios market. Besides critical data and related information, the report includes key trends (both present and future), factors that are driving market growth, factors that are or could be potential restraints to market growth, as well as opportunities that can be leveraged for potential revenue generation in untapped regions and countries. It also covers threats or challenges for existing as well as new entrants in the market. The global canine atopic dermatitis market has been segmented on the basis of product, mode of administration, distribution channel, as well as regions and countries.

The Global Canine Atopic Dermatitis market size was valued at USD $32859.09 Million in 2020, USD $35714.55 Million in 2021, forecasted to reach  USD $38818.14 Million in 2022, and is projected to reach USD $105999.59 Million by 2030, and is anticipated to expand at a CAGR of 8.69% over the forecast period from 2020 to 2030.

Overview:

Atopic dermatitis is a pruritic (itchy) skin disease, common among cats and dogs. This condition is the result of an allergic reaction that occurs when an animal inhales airborne substances (dust, pollen) or ingests a substance that they are sensitive to. This allergic reaction causes the animal to lick, rub, bite, or scratch the affected surface area.

Dynamics:

The surging number of veterinary practitioners is a primary factor that is expected to fuel revenue growth of the global canine atopic dermatitis market in the years to come. Additionally, the rising number of veterinary clinics and hospitals are also expected to contribute to future revenue growth.

Other factors that are anticipated to play a crucial role in the revenue growth of this global market are a strong drug pipeline, new product launches, as well as increasing investments being made by key industry players. Furthermore, the stringent enforcement of regulations by governing bodies such as the Food and Drug Administration (FDA) to lower the off label usage of human drugs on animals is slated to boost future market growth. The increasing concern among pet owners, as well as the demand for pet insurance are also expected to positively influence this market.

Segmentation of the global canine atopic dermatitis market is as follows:

In terms of product, the glucocorticoids segment accounted for the majority revenue share of the global canine atopic dermatitis market in 2019, owing to its cheaper cost and increased usage. The Monoclonal Antibodies (MAbs) segment is expected to index considerable revenue growth in the foreseeable future.

On the basis of mode of administration, the oral segment accounted for the highest number of revenue shares of the global canine atopic dermatitis market. Although, the injectable segment is expected to index substantial revenue growth due to its potency and efficacy.

With respect to distribution channel, the retail segment accounted for the highest revenue shares of this global market in 2019, due to increased product availability. The increasing popularity of e-commerce channels due to greater convenience levels is further contributing to future revenue sales of this global market.

Regional Segmentation and Analysis:

North America accounted for the majority revenue share of the global canine atopic dermatitis market in 2019, and is expected to continue to do so over the next 10 years. This can be attributed to the increasing incidence of atopic dermatitis, new product launches, as well as the rising number of pet owners in this region.

Below are the leading companies profiled in this Canine Atopic Dermatitis Market Report:

  
AB Science SA
  
Bimeda, Inc.
  
Bioiberica S.A.U.
  
Boehringer Ingelheim International GmbH
  
CEVA SANTE ANIMALE
  
Dechra Pharmaceuticals PLC
  
Deep Marine Collagen
  
Elanco
  
Kindred Biosciences Inc.
  
Merck & Co. Inc.
  
Nippon Zenyaku Kogyo Co., Ltd.
  
Novartis AG
  
Solarc Systems Inc.
  
Toray Industries Inc.
  
Vetoquinol S.A.
  
Virbac
  
Zoetis Inc.

Segmentation of the Global Canine Atopic Dermatitis Market:

By Product:

  
Glucocorticoids
  
Antihistamines
  
Immunosuppressants
  
MAbs
  
Others

By Mode of Administration

  
Topical
  
Oral
  
Injectable

By Distribution Channel

  
Veterinary Hospitals/Clinics
  
Retail
  
E-commerce
This research comprehensively answers the following 9 important questions:

  
Q.1. What are some of the most promising growth trends in the Canine Atopic Dermatitis market worldwide?
  
Q.2.Which segments and sub-segments will grow at a faster pace and why? Which segment is nearing the peak and demand saturation?
  
Q.3.Which region will witness a higher growth rate and why? Which region might see a slower or negative growth region?
  
Q.4.What are the key factors affecting market dynamics? What are the drivers, challenges, and business risks in Canine Atopic Dermatitis market?
  
Q.5.What are the business risks and who pose challenges to the global leaders and are competitive threats in this Canine Atopic Dermatitis market?
  
Q.6.What are the emerging trends post COVID-19 reshuffle in this Canine Atopic Dermatitis market and the what are reasons behind these trends and do they translate in global exploration?
  
Q.7. Who are the major global and regional players in the Canine Atopic Dermatitis market? Which are the strategic initiatives key players are pursuing for business growth?
  
Q.8.Which are the competing products in Canine Atopic Dermatitis market and how big of a threat do they pose for loss of market share by material or product substitution?
  
Q.9.What M & A activity has occurred in the last 5 years and what is its impact on the Canine Atopic Dermatitis industry?